miR-124 and androgen receptor signaling inhibitors repress prostate cancer growth by downregulating androgen receptor splice variants, EZH2 and Src
Shi, X.-B.; Ma, A.; Xue, L.; Li, M.; Nguyen, H. G.; Yang, J. C.; Tepper, C. G.; Gandour-Edwards, R.; Evans, C. P.; Kung, H.-J.; de Vere White, R. W.
- 期刊名称Cancer Research
- 作者Shi, X.-B.; Ma, A.; Xue, L.; Li, M.; Nguyen, H. G.; Yang, J. C.; Tepper, C. G.; Gandour-Edwards, R.; Evans, C. P.; Kung, H.-J.; de Vere White, R. W.
- 印刷ISSN0008-5472
- 电子ISSN1538-7445
- 文件大小989.05KB
- 发表时间2015-11-16
- DOI10.1158/0008-5472.can-14-0795